Neurobiology of Aging
Volume 30, Issue 9 , Pages 1406-1412 , September 2009

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression

  • B. Borroni

      Affiliations

    • Center for Aging Brain and Dementia, Department of Neurology, University of Brescia, Italy
    • Corresponding Author InformationCorresponding author at: Clinica Neurologica, Università degli Studi di Brescia, Pza Spedali Civili, 1-25100 Brescia, Italy. Tel.: +39 0303995632; fax: +39 0303995027.
  • ,
  • S. Archetti

      Affiliations

    • III Laboratory of Biotechnology, University of Brescia, Italy
  • ,
  • C. Costanzi

      Affiliations

    • Center for Aging Brain and Dementia, Department of Neurology, University of Brescia, Italy
  • ,
  • M. Grassi

      Affiliations

    • Department of Health Sciences, Section of Medical Statistics & Epidemiology, University of Pavia, Italy
  • ,
  • M. Ferrari

      Affiliations

    • III Laboratory of Biotechnology, University of Brescia, Italy
  • ,
  • A. Radeghieri

      Affiliations

    • III Laboratory of Biotechnology, University of Brescia, Italy
  • ,
  • L. Caimi

      Affiliations

    • III Laboratory of Biotechnology, University of Brescia, Italy
  • ,
  • C. Caltagirone

      Affiliations

    • Department of Neurology, University “Tor Vergata”, Rome and IRCCS Santa Lucia, Rome, Italy
  • ,
  • M. Di Luca

      Affiliations

    • Department of Pharmacological Sciences, University of Milan, Italy
  • ,
  • A. Padovani

      Affiliations

    • Center for Aging Brain and Dementia, Department of Neurology, University of Brescia, Italy
  • ,
  • for the ITINAD Working Group

Received 23 July 2007 ,Revised 22 October 2007 ,Accepted 24 November 2007.

References 

  1. American Psychiatric Association . In: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed.. Washington, DC: American Psychiatric Association Press; 2000;
  2. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311(5762):864–868
  3. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry. 2006;59(9):812–815
  4. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry. 2001;50(4):260–265
  5. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004;24(18):4401–4411
  6. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res. 2006;1118(1):176–182
  7. Combarros O, Infante J, Llorca J, Berciano J. Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2004;18(1):55–58
  8. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314
  9. Desai P, Nebes R, DeKosky ST, Kamboh MI. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci. Lett. 2005;379(3):229–234
  10. Duman RS. Synaptic plasticity and mood disorders. Mol. Psychiatry. 2002;7(Suppl. 1):S29–S34
  11. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269
  12. Folstein MF, Folstein SE, McHugh PR: . “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 1975;12:189–198
  13. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology. 2005;51(4):234–238
  14. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005;255(6):381–386
  15. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 1982;140:566–572
  16. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol. Aging. 2006;27(12):1834–1837
  17. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109(2):143–148
  18. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 2007;61(1):3–19
  19. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol. Aging. 2008;29:789–792
  20. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol. Psychiatry. 2001;6(1):83–86
  21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186
  22. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol. Psychiatry. 2003;54(3):353–362
  23. Levinson DF. The genetics of depression: a review. Biol. Psychiatry. 2006;60(2):84–92
  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939–944
  25. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34(1):13–25
  26. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995;15(11):7539–7547
  27. Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, et al. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J. Mol. Neurosci. 2004;22(3):257–260
  28. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 2004;24(45):10099–10102
  29. Proschel M, Saunders A, Roses AD, Muller CR. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum. Mol. Genet. 1992, Aug;1(5):353
  30. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Muller U, Forstl H, et al. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol. Psychiatry. 2002;7(7):782–785
  31. Russo-Neustadt AA, Chen MJ. Brain-derived neurotrophic factor and antidepressant activity. Curr. Pharm. Des. 2005;11(12):1495–1510
  32. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry. 2005;58(4):307–314
  33. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J. Neurosci. 2002;22(8):3251–3261
  34. Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology. 2004;49(1):10–12
  35. Tsai SJ. Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease?. Med. Hypotheses. 2003;61(1):110–113
  36. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol. Psychiatry. 2002;7(2):136–137
  37. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 1983;17:37–49

PII: S0197-4580(07)00458-7

doi: 10.1016/j.neurobiolaging.2007.11.023

Neurobiology of Aging
Volume 30, Issue 9 , Pages 1406-1412 , September 2009